A new hope for the treatment of Coronavirus could come from a molecule to treat acute pancreatitis, Gabesate mesilate.
La doctor Annalisa Capuanor, clinical pharmacologist of the Vanvitelli, said he was waiting for theAifa authorization (Italian Medicines Agency) to start with the experimentation of a promising molecule to cure the Coronavirus.
Mesylated gabesate
It seems that the molecule Mesylated gabesate, usually used to treat the acute pancreatitis, can give excellent results to cure and thwart covid-19.
It turned out that if administered within 48 hours of the first symptoms, manages to have a positive impact on the three phases of the Coronavirus.
Il Covid-19 in fact, in the first phase it begins to replicate, in the second phase the organism is unable to counteract this replication and in the third there is a great inflammation that causes important vascular changes.
A new hope
It seems that the Coronavirus hook to some enzymes found on the surface of the lung cells and that from here it reaches the target cells, then invading the organism.
The hope of the molecule gabesato is that it somehow manages to counteract the access of the virus into cells.
Another important fact is that it seems that this molecule has a quite good tolerability profile.
So once that the Aifa will give her permission, the doctor Capuan can start with the care of about 80 patients, hoping that real results can be obtained for the treatment of the disease.
